-
Release of lipopolysaccharide by EDTA treatment of E. coli.
Biochem Biophys Res Commun. 1965 Nov 22;21(4):290-6
PMID: 4159978
-
Studies on the mechanism of bacterial resistance to complement-mediated killing and on the mechanism of action of bactericidal antibody.
Curr Top Microbiol Immunol. 1985;121:99-133
PMID: 3910367
-
Sensitivity of rough gram-negative bacteria to the bactericidal action of serum.
J Bacteriol. 1968 May;95(5):1647-50
PMID: 5650074
-
[Studies on the immune bacteriolysis. XIV. Requirement of all nine components of complement for immune bacteriolysis].
Biken J. 1968 Sep;11(3):203-6
PMID: 4888628
-
Sensitivity of Pseudomonas aeruginosa to normal serum and to polymyxin.
J Bacteriol. 1969 May;98(2):453-7
PMID: 4306538
-
The serum bactericidal reaction. 3. Antibody and complement requirements for killing a rough Escherichia coli.
J Immunol. 1969 Jun;102(6):1379-87
PMID: 4891549
-
The sensitivity of smooth and rough gram-negative bacteria to the immune bactericidal reaction.
Proc Soc Exp Biol Med. 1970 Jan;133(1):345-8
PMID: 4904564
-
Human immunity to Pseudomonas aeruginosa. I. In-vitro interaction of bacteria, polymorphonuclear leukocytes, and serum factors.
J Infect Dis. 1972 Sep;126(3):257-76
PMID: 4626509
-
Elastase of Pseudomonas aeruginosa: inactivation of complement components and complement-derived chemotactic and phagocytic factors.
Infect Immun. 1974 Jul;10(1):128-35
PMID: 4210424
-
Pseudomonas aeruginosa infection in cystic fibrosis. Bactericidal effect of serum from normal individuals and patients with cystic fibrosis on P. aeruginosa strains from patients with cystic fibrosis or other diseases.
Acta Pathol Microbiol Scand C. 1977 Apr;85(2):107-14
PMID: 404841
-
Bactericidal activity of the alternative complement pathway generated from 11 isolated plasma proteins.
J Exp Med. 1979 Apr 1;149(4):870-82
PMID: 372483
-
Synergy between carbenicillin and an aminoglycoside (gentamicin or tobramycin) against Pseudomonas aeruginosa isolated from patients with endocarditis and sensitivity of isolates to normal human serum.
J Infect Dis. 1979 Aug;140(2):192-202
PMID: 113468
-
Plasmid-determined resistance to serum bactericidal activity: a major outer membrane protein, the traT gene product, is responsible for plasmid-specified serum resistance in Escherichia coli.
Infect Immun. 1980 May;28(2):359-67
PMID: 6995306
-
Determinants that increase the serum resistance of Escherichia coli.
Infect Immun. 1980 Jul;29(1):278-80
PMID: 6995340
-
Large scale isolation of functionally active components of the human complement system.
J Biol Chem. 1981 Apr 25;256(8):3995-4006
PMID: 6783652
-
Serum bactericidal effect on Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Infect Immun. 1981 Aug;33(2):512-8
PMID: 6792079
-
Studies on the mechanism of bacterial resistance to complement-mediated killing. II. C8 and C9 release C5b67 from the surface of Salmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membrane.
J Exp Med. 1982 Mar 1;155(3):809-19
PMID: 6801180
-
Serum-induced lysis of Pseudomonas aeruginosa.
Eur J Clin Microbiol. 1982 Feb;1(1):1-6
PMID: 6816583
-
Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains.
Infect Immun. 1983 Oct;42(1):170-7
PMID: 6413410
-
The serum sensitivity, colonial morphology, serogroup specificity, and outer membrane protein of Pseudomonas aeruginosa strains isolated from several clinical sites.
Diagn Microbiol Infect Dis. 1983 Jun;1(2):145-57
PMID: 6425002
-
Blink reflex in trigeminal sensory neuropathy.
Electromyogr Clin Neurophysiol. 1984 Mar-Apr;24(3):185-90
PMID: 6714147
-
Mechanism of bacterial resistance to complement-mediated killing: inserted C5b-9 correlates with killing for Escherichia coli O111B4 varying in O-antigen capsule and O-polysaccharide coverage of lipid A core oligosaccharide.
Infect Immun. 1984 Jul;45(1):113-7
PMID: 6203836
-
Interaction of human complement proteins with serum-sensitive and serum-resistant strains of Escherichia coli.
Mol Immunol. 1984 Jul;21(7):609-20
PMID: 6379418
-
Serum sensitivity of a Pseudomonas aeruginosa mucoid strain.
Infect Immun. 1984 Sep;45(3):748-55
PMID: 6432698
-
Serum-resistant mutants of Escherichia coli O111 contain increased lipopolysaccharide, lack an O antigen-containing capsule, and cover more of their lipid A core with O antigen.
J Bacteriol. 1984 Sep;159(3):877-82
PMID: 6207166
-
A plasmid-encoded outer membrane protein, TraT, enhances resistance of Escherichia coli to phagocytosis.
Infect Immun. 1984 Dec;46(3):740-6
PMID: 6389361
-
C3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I.
J Exp Med. 1984 Dec 1;160(6):1640-55
PMID: 6239898
-
Role of lipopolysaccharide in opsonization and phagocytosis of Pseudomonas aeruginosa.
Infect Immun. 1985 Jul;49(1):182-9
PMID: 3924827
-
A quantitative method for assessing the third complement factor (C3) attached to the surface of opsonized Pseudomonas aeruginosa: interrelationship between C3 fixation, phagocytosis and complement consumption.
J Immunol Methods. 1985 Jul 16;81(1):43-53
PMID: 3926902
-
C3 binds preferentially to long-chain lipopolysaccharide during alternative pathway activation by Salmonella montevideo.
J Immunol. 1986 Jan;136(2):710-5
PMID: 2416822
-
Analyses of lipopolysaccharides extracted from penicillin-resistant, serum-sensitive salmonella mutants.
J Gen Microbiol. 1967 Aug;48(2):179-88
PMID: 5341578